2025-2026 Regular SessionIllinois Legislature

HB3087: METHAMPHETAMINE PRECURSORS

Legislative Summary

Amends the Methamphetamine Precursor Control Act. Provides that each targeted methamphetamine precursor package shall contain no more than 3,600 (rather than 3,000) milligrams of ephedrine or pseudoephedrine, their salts or optical isomers, or salts of optical isomers. Deletes a provision which specifies that no retail distributor operating a pharmacy, and no pharmacist or pharmacy technician, shall knowingly distribute to a single person more than 2 targeted packages in a single retail transaction. Amends the Methamphetamine Precursor Tracking Act. Provides that, on and after October 1, 2025, any manufacturer of products containing methamphetamine precursors sold in or brought into the State must, on a monthly basis, pay fees to the Central Repository. Provides that the Central Repository shall be responsible for setting the fee levels required. Provides that at the request of the Illinois State Police, manufacturers required to pay fees shall be required to provide written documentation demonstrating that they have paid such fees. Provides that the sale of methamphetamine precursors in or brought into the State by a manufacturer who has failed to pay fees required by the provision is guilty of a petty offense and subject to a fine of $500 for a first offense; $1,000 for a second offense occurring within 3 years of the first offense; and $5,000 for a third or subsequent offense occurring within 3 years of the prior offenses. Effective immediately.

Demographic Impact

Overall analysis of equity impact

Neutral
Medium ConfidenceView detailed demographic breakdown ↓

Unlock Full Demographic Insights

Go beyond the overall score.

Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.

Enable full analysis features for your organization.

Contact Sales to Learn More

Or email us directly at sales@legiequity.us.

Bill History

2/6/2025
Filed with the Clerk by Rep. Martin J. Moylan
House of Representatives
2/6/2025
First Reading
House of Representatives
2/6/2025
Referred to Rules Committee
House of Representatives
3/4/2025
Assigned to Judiciary - Criminal Committee
House of Representatives
3/17/2025
House Committee Amendment No. 1 Filed with Clerk by Rep. Martin J. Moylan
House of Representatives
3/17/2025
House Committee Amendment No. 1 Referred to Rules Committee
House of Representatives
3/18/2025
House Committee Amendment No. 1 Rules Refers to Judiciary - Criminal Committee
House of Representatives
3/18/2025
House Committee Amendment No. 1 Adopted in Judiciary - Criminal Committee; by Voice Vote
House of Representatives
3/18/2025
Do Pass as Amended / Short Debate Judiciary - Criminal Committee; 012-000-000
House of Representatives
3/19/2025
Placed on Calendar 2nd Reading - Short Debate
House of Representatives
3/25/2025
Second Reading - Short Debate
House of Representatives
3/25/2025
Placed on Calendar Order of 3rd Reading - Short Debate
House of Representatives
4/8/2025
Third Reading - Short Debate - Passed 115-000-000
House of Representatives
4/8/2025
Added Chief Co-Sponsor Rep. Martin McLaughlin
House of Representatives
4/8/2025
Added Chief Co-Sponsor Rep. Anthony DeLuca
House of Representatives
4/9/2025
Arrive in Senate
Senate
4/9/2025
Placed on Calendar Order of First Reading April 10, 2025
Senate
4/14/2025
Chief Senate Sponsor Sen. Mike Porfirio
Senate
4/14/2025
First Reading
Senate
4/14/2025
Referred to Assignments
Senate
4/23/2025
Assigned to Public Health
Senate

Amendments

House Amendment 001

House Amendment 001

3/17/2025Not Adopted

Roll Call Votes

Third Reading in House
4/8/2025
115
Yea
0
Nay
0
Not Voting
0
Absent
Result: PASSED

Status Information

Current Status
Engrossed(4/8/2025)
Chamber
Senate
Committee
Public Health(Senate)

Sponsors

Documents

Engrossed
Bill Text3/25/202528.8 KB
Introduced
Bill Text2/6/202531.1 KB